Recursive, an AI startup founded last year, is starting to live up to its name. The company, which is trying to build AI that can improve itself, released its first model, Flint, on Wednesday. Flint ...

For the past few days I’ve been testing an impressive open-weight AI coding model called Flint. It suggests that fully recursive self-improvement, or RSI—an exciting and controversial approach that ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

\HH(p_1,\ldots,p_q)=-\sum_i p_i\log p_i. Zero-mass contributions are zero. The sum of the three rates is \(\HH(\pi)\). This identity is the entropy chain rule \cite[Section~6]{shannon1948}. The exact ...

Pinching pennies at the supermarket seems to be a common thread these days, and sometimes that means shopping at stores that aren't normally in someone's wheelhouse. Even if you wanted to buy a ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Regan Peng is an AI founder and former senior tech executive, focused on personal AI, ...

Olivia Rodrigo‘s Daisy Chain Fields Festival was a success, raising $20 million, which will be donated to charities that benefit women. Following the festival, the “Good 4 U” singer took to social ...

The inaugural, sold-out Daisy Chain Fields music festival, founded by Olivia Rodrigo, was a moment of celebration, community, and hope from the second that attendees stepped on the grounds of the ...

Some subscribers prefer to save their log-in information so they do not have to enter their User ID and Password each time they visit the site. To activate this function, check the 'Keep me signed in' ...

A new dispensary will open in Farmingdale this fall as competition among Long Island’s burgeoning cannabis industry heats up. Los Angeles-based chain The Artist Tree plans to open its new store at 900 ...

Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth challenge its AI-driven drug discovery ambitions. RXRX's partnerships, notably with Genentech/Roche and ...